Brief: Panbela Therapeutics Announces $5.0 Million Bought Deal Offering Of Common Stock
June 29 (Reuters) - Panbela Therapeutics Inc PBLA.O :
* PANBELA THERAPEUTICS ANNOUNCES $5.0 MILLION BOUGHT DEAL
OFFERING
OF COMMON STOCK
* PANBELA - UNDERWRITER AGREED TO PURCHASE ON FIRM
COMMITMENT
BASIS 1.7 MILLION SHARES OF COMMON STOCK AT PRICE TO PUBLIC OF
$3.00 PER SHARE
* PANBELA - HAS GRANTED TO UNDERWRITER 30-DAY OPTION TO
PURCHASE
UP TO AN ADDITIONAL 250,000 SHARES OF COMMON STOCK AT PUBLIC
OFFERING PRICE
Source text for Eikon: ID:nGNX7r7W55
Further company coverage: PBLA.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Panbela Therapeutics
See all newsBrief: Panbela Therapeutics Announces Third Independent Safety Review Of Phase 3 Aspire Clinical Trial DSMB Recommended Continuation With No Trial Modification
Brief: Nasdaq Notifies Panbela Therapeutics Notice Of Delisting Or Failure To Satisfy A Continued Listing Rule Or Standard
Brief: Panbela Announces Pricing of Approximately $9 Mln Public Offering
U.S. STOCKS ON THE MOVE-Fisker, Best Buy, NuStar Energy
Brief: Panbela Therapeutics Announces Exercise Of Warrants And Issuance Of New Warrants